Catalyst Biosciences Inc (CBIO)

1.195 -0.04  -2.85% NASDAQ Nov 30, 16:00 1.195 0.00  0.00% After-Hours: 20:00 USD

Catalyst Biosciences Cash from Financing (TTM):

49.55M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2005. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 49.55M
June 30, 2021 49.38M
March 31, 2021 77.47M
Dec. 31, 2020 60.38M
Sept. 30, 2020 60.38M
June 30, 2020 60.54M
March 31, 2020 32.58M
Dec. 31, 2019 0.327M
Sept. 30, 2019 0.398M
June 30, 2019 0.306M
March 31, 2019 0.214M
Dec. 31, 2018 111.33M
Sept. 30, 2018 122.20M
June 30, 2018 121.92M
March 31, 2018 137.28M
Dec. 31, 2017 21.08M
Sept. 30, 2017 10.23M
June 30, 2017 11.22M
March 31, 2017 -4.022M
Dec. 31, 2016 0.948M
Sept. 30, 2016 1.032M
June 30, 2016 9.507M
March 31, 2016 9.22M
Dec. 31, 2015 9.313M
Sept. 30, 2015 8.668M
   
June 30, 2015 -0.739M
March 31, 2015 -0.802M
Dec. 31, 2014 2.572M
Sept. 30, 2014 3.028M
June 30, 2014 3.09M
March 31, 2014 3.121M
Dec. 31, 2013 -0.552M
Sept. 30, 2013 -0.725M
June 30, 2013 -0.341M
March 31, 2013 -0.325M
Dec. 31, 2012 -0.626M
Sept. 30, 2012 -0.969M
June 30, 2012 -1.714M
March 31, 2012 81.74M
Dec. 31, 2011 82.81M
Sept. 30, 2011 85.36M
June 30, 2011 87.08M
March 31, 2011 6.152M
Dec. 31, 2010 6.446M
Sept. 30, 2010 51.90M
June 30, 2010 51.07M
March 31, 2010 48.36M
Dec. 31, 2009 47.18M
Sept. 30, 2009 -0.6773M
June 30, 2009 -0.8018M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Johnson & Johnson --
Arbutus Biopharma Corp 98.32M
IVERIC bio Inc 109.56M

Cash from Financing (TTM) Range, Past 5 Years

Minimum -4.022M Mar 2017
Maximum 137.28M Mar 2018
Average 46.19M

News

Top Midday Decliners
MT Newswires 11/12 13:52 ET
Top Premarket Decliners
MT Newswires 11/12 08:07 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.